Formulation of glycerolipidic prodrugs into PEGylated liposomes for brain delivery

Journal of Drug Delivery Science and Technology

Volumn 19, Issue 1, 2009, Pages 61-66

  Bourgeois, J ^a   Lalanne, M ^a   Pierson, L A ^a   Marsaud, V ^a   Nicolas, V ^a   Tsapis, N ^a   Ball, R ^b   Stanimirovic, D ^b   Couvreur, P ^a   Andrieux, Karine ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

BBB in vitro model; Brain delivery; Didanosine; Formulation optimization; Glycerolipidic prodrug; HIV; PEGylated liposome

Indexed keywords

DIDANOSINE; LIPOSOME;

ANIMAL CELL; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DEMENTIA; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BRAIN LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PENETRATION; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; LIGHT SCATTERING; LIPOSOMAL DELIVERY; MICROSCOPY; NONHUMAN; PARTICLE SIZE; PROCESS OPTIMIZATION; RAT;

EID: 59849122948     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(09)50008-1     Document Type: Article

References (19)

1. Lalanne M., Paci A., Andrieux K., Dereuddre-Bosquet N., Clayette P., Deroussent A., Re M., Vassal G., Couvreur P., Desmaele D. - Synthesis and biological evaluation of two glycerolipidic prodrugs of didanosine for direct lymphatic delivery against HIV. - Bioorg Med Chem Lett., 17 (8), 2237-40, 2007.
2. Balimane P.V., Sinko P.J. - Involvement of multiple transporters in the oral absorption of nucleoside analogues. - Adv. Drug Deliv. Rev., 39 (1-3), 183-209, 1999.
3. Lambert D.M. - Rationale and applications of lipids as prodrug carriers. - Eur. J. Pharm. Sci., 2, S15-S27, 2000.
4. Lalanne M., Andrieux K., Paci A., Besnard M., Re M., Bourgaux C., Ollivon M., Desmaele D., Couvreur P. - Liposomal formulation of a glycerolipidic prodrug for lymphatic delivery of didanosine via oral route. - Int J Pharm., 344 (1-2), 62-70, 2007.
5. Lawrence D.M., Major E.O. - HIV-1 and the brain: connections between HIV-1-associated dementia, neuropathology and neuroimmunology. - Microbes Infect., 4 (3), 301-8, 2002.
6. Yatvin M.B., Li W., Meredith M.J., Shenoy M.A. - Improved uptake and retention of lipophilic produg to improve treatment of HIV. - Adv. Drug Del. Rev., 39, 165-182, 1999.
7. Garcia-Garcia E., Andrieux K., Gil S., Couvreur P. - Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain? - Int. J. Pharm., 298 (2), 274-92, 2005.
8. Shashoua V.E., Hesse G.W. - N-Docosahexaneoyl, 3-Hydroxytyramine: a dopaminergic compound that penetrate the blood brain barrierand suppresses appetite. - Life Sci., 58 (16) 1347-57, 1996.
9. Wiebe L.I., Knaus E.E. - Concepts for the design of anti-HIV nucleoside prodrugs for treating cephalic HIV infection. - Adv. Drug Del. Rev., 39, 63-80, 1999.
10. Brigger I., Morizet J., Aubert G., Chacun H., Terrier-Lacombe M.J., Couvreur P., Vassal G. - Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting. - J Pharmacol Exp Ther., 303 (3), 928-36, 2002.
11. Kim H.R., Gil S., Andrieux K., Nicolas V., Appel M., Chacun H., Desmaele D., Taran F., Georgin D., Couvreur P. - Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells. - Cell Mol Life Sci., 64 (3), 356-64, 2007.
12. Bangham A.D., Hill H.W., Miller N.G.A. - Preparation and use of liposomes as models of biological membranes. - Methods Membr. Biol., 1, 1-68, 1974.
13. Muruganandam A., Herx L.M., Monette R., Durkin J.P., Stanimirovic D.B. - Development of immortalised human cerebromicrovascular endothelial cell line as an in vitro model of the human blood-brain barrier. - Faseb J., 11 (13), 1187-97, 1997.
14. Garberg P., Ball M., Borg N., Cecchelli R., Fenart L., Hurst R.D., Lindmark T., Mabondzo A., Nilsson J.E., Raub T.J., Stanimirovic D., Terasaki T., Oberg J.O., Osterberg T. - In vitro models for the blood-brain barrier. - Toxicol In vitro, 19 (3), 299-334, 2005.
15. Unezaki S., Maruyama K., Takahashi N., Koyama M., Yuda T., Suginaka. A., Iwatsuru M. - Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethylene glycol in combination with local hyperthermia. - Pharm Res., 11 (8), 1180-5, 1994.
16. Singh M., Ferdous A.J., Jackson T.L. - Stealth monensin liposomes as a potentiator of adriamycin in cancer treatment. - J Control Release, 59 (1), 43-53, 1999.
17. Kreuter J., Gelperina S. - Use of nanoparticles for cerebral cancer. - Tumori., 94 (2), 271-7, 2008.
18. Garcia-Garcia E., Gil S., Andrieux K., Desmaële D., Nicolas V., Taran F., Georgin D., Andreux J., Roux F., Couvreur P. - A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles. - Cellular and Molecular Life Sciences (CMLS), 62 (12), 1400-1408, 2005.
19. Kim H.R., Andrieux K., Gil S., Taverna M., Chacun H., Desmable D., Taran F., Georgin D., Couvreur P. - Translocation of poly(ethylene glycol-co-hexadecyl)-cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins on receptor-mediated endocytosis. - Biomacromol, 12 (3),793-799, 2007.